People · Operator
Named in public records as an officer, director or promoter · active 2018–2024 · Pharmaceuticals, Software / Tech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Inozyme Pharma, Inc. | — | Pharmaceuticals | Series C | $116.2M | $2.4B | 2018 |
| Little Sparrows Technologies, Inc. | — | Software / Tech | Seed | $2.0M | $1.7M | 2024 |
DOUGLAS TRECO at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside DOUGLAS TRECO on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Edward Mathers | 1 | 12 |
| Axel Bolte | 1 | 6 |
| Rob Hopfner | 1 | 6 |
| Martin Edwards | 1 | 5 |
| Lynne Sullivan | 1 | 3 |
| FRANCIS KIM | 1 | 2 |
| Joseph Schlessinger | 1 | 2 |
| Reinaldo Diaz | 1 | 1 |
| GEORGIA MCGAUGHEY NICHOLLS | 1 | 1 |
| DONNA BREZINSKI | 1 | 1 |
| GARY GILBERT | 1 | 1 |
| Donna J. Brezinski | 1 | 1 |
| Gary E. Gilbert | 1 | 1 |
| Sarah Bhagat | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.